January 12, 2009 8:30 am Move Over, Botox The FDA is expected to approve Reloxin – a competitor to Botox – that is cheaper, faster, and longer-lasting. Local 0:37 Ex-Abercrombie CEO arrested on sex trafficking-related charges 9:07 Selena Gomez and Benny Blanco's sweetest moments 2:13 Real-life ‘Karate Kid' meets his inspiration 2:12 What to expect in court as Trump faces 2020 election charges in DC 0:54 Parents can start helping teenagers to build a financial foundation at home without spending
